Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06338826
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-01
First Post:
2023-11-27
Brief Title:
Study Evaluating the Safety in Terms of HBV Virological Control at 96 Weeks of 2 Antiviral Treatment Relief Strategies in Patients Co-infected With the HIV-1 and HBV Viruses
Sponsor:
ANRS Emerging Infectious Diseases
Organization:
ANRS Emerging Infectious Diseases
Study Overview
Official Title:
Interventional Multicenter Open-label Randomized Non-comparative Trial Evaluating the Safety in Terms of HBV Virological Control at 96 Weeks of 2 Antiviral Treatment Relief Strategies in Patients Co-infected With the HIV-1 and HBV Viruses
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BI-LIGHT
Brief Summary:
The main objective of this study is to evaluate at 96 weeks the safety with respect to hepatitis B control of 2 treatment reduction strategies for patients with previously controlled HIV-HBV co-infection on continuous triple therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None